"Professor Adam Cribbs leads a computational biology team with expertise in systems biology, immunology, and epigenetics. He earned his PhD in molecular T-cell immunology from Imperial College London in May 2013 and subsequently held a two-year postdoctoral position at the University of Oxford, where he explored the epigenetics of T-cell activation. Following this, Professor Cribbs completed a three-year Medical Research Council (MRC) Fellowship in Computational Biology under the Computational Genomics and Training Centre (CGAT) program, mentored by Professor Chris Ponting. In 2018, he was appointed as a group leader in systems biology at the Botnar Research Centre, and in January 2021, he began a five-year MRC Career Development Fellowship. The research focus of the Cribbs laboratory is to unravel disease biology from a functional genomics standpoint. The team is committed to advancing our understanding of the regulatory mechanisms that influence genes, proteins, and biological pathways, with the aim of deciphering disease processes and identifying novel therapeutic targets. The laboratory's research activities span several primary and secondary bone cancers, including multiple myeloma and Ewing's sarcoma, and are involved in numerous highly collaborative projects such as the Tendon Seed Network, the Oxford-Bayer Alliance in Women’s Health, and the Oxford Centre for Translational Myeloma Research. In addition to his academic and research responsibilities, Professor Cribbs is the Chief Technology Officer (CTO) of Caeruleus, a company founded in January 2023 that specializes in long-read single-cell sequencing. "